What's New @ PMPRB
To order any publication, please include this form or call our toll-free number 1-877-861-2350.
The public hearing in the matter of Janssen-Ortho Inc, and the medicine Risperdal Consta is scheduled to continue November 27 to 29, 2006, starting at 9:30 a.m., in the Board's Offices, 333 Laurier Avenue West, 18th floor, Hearing Room #2, Ottawa. For more information, please contact the Secretary of the Board at (613) 954-8299.
The public hearing in the matter of 3M Canada Company and the medicine Airomir, scheduled to start on October 16, has been postponed. An update will be posted as soon as a hearing date has been confirmed. For more information, please contact the Secretary of the Board at (613) 954-8299 or at sdupont@pmprb-cepmb.gc.ca.
The public hearing in the matter of Janssen-Ortho Inc, and the medicine Risperdal Consta is scheduled to continue September 28 and 29, 2006, starting at 9:30 a.m., in the Board's Offices, 333 Laurier Avenue West, 18th floor, Hearing Room #1, Ottawa. For more information, please contact the Secretary of the Board at (613) 954-8299.
The Board has accepted three Voluntary Compliance Undertakings (VCUs) for the medicines: